Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
theophylline
KRKA d.d.
R03DA04
theophylline
350mg
capsules modified-release
(40/4x10/) in blister
Prescription
Registered
2017-04-03
91 /263
SPC,
Labelin
lIine
1.3.1
YTBEP)K.nEHA
npRKa30M
npe,[(ce,[(aTeJUI
KOMRTeTa
KOHTPOJIli
Me,[(RUHHcKOH
R
cpapMaueBTIi"leCKOH
,[(ellTeJIbHOCTIi
MIiHlicTepcTBa
3,[(paBooxpaHeHli1i
Ii
COUHaJIbHOrO pa3BIiTlili
Pecny6JIliKIi
Ka3axCTaH
OT «24»
06
2015
r.
_N!?468_
HHCTPYKUHH no Me.llHUHHCKOMY npHMeHeHHIO
JleKapCTBeHHoro
Cpe.llCTBa
TEOTAP,L{
ToprOBoe
Ha3BaHHe
TeoTap'[(
MelK.!lYHapO.llHOe
HenaTeHTOBaHHoe
Ha3BaHHe
HeT
JIeKapcTBeHHaH
cpopMa
KancYJIbl
C MO'[(HCPI1URpOBaHHblM BblcBo6o)f()leHHeM
200
Mr
HJIH 350
Mr
COCTaB:
O'[(Ha
KancYJIa
cO)lep)!(IiT
_aKmU6Hoe 6ezqecm60 -_
Teo
Read the complete document
1.3.1 Theophylline SPC, Labeling and Package Leaflet SmPCPIL153842_1 25.08.2020 – Updated: 25.08.2020 Page 1 of 8 1. NAME OF THE MEDICINAL PRODUCT Teotard 200 mg modified-release capsules Teotard 350 mg modified-release capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each modified-release capsule contains 200 mg or 350 mg theophylline. For excipients, see 6.1. 3. PHARMACEUTICAL FORM Modified-release capsules. Teotard modified-release capsules 200 mg: The capsule body is transparent and green, the cap is non-transparent and green; the capsules contain white pellets. Teotard modified-release capsules 350 mg: The capsule body is transparent and green, the cap is non-transparent and green; the capsules contain white pellets. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS All types of asthma, chronic obstructive bronchitis, pulmonary emphysema, pulmonary hypertension in chronic cor pulmonale, centrally induced respiratory disorders during sleep. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Dosage must be adjusted according to the patient’s age, body mass and individual and individual metabolic requirements and is therefore always determined by a doctor. The size of the dose is determined according to the patient’s ideal body weight, as theophylline is not distributed into adipose tissues. The usual dose for adults weighing more than 40 kg is 350 mg theophylline twice daily and for very thin adults 200 mg theophylline twice daily. Patients with nocturnal asthma or respiratory disorders during sleep can take one dose of Teotard daily, at bedtime. On average, 400 to 700 mg theophylline is sufficient. Smokers may take unequal doses, i.e. a higher dose in the evening and a lower dose in the morning. The therapeutic effect and tolerability of theophylline are evaluated on the third day of treatment. If the therapeutic effect is good, treatment is continued with the same dose. If not, the dose should be increased. If undesirable effects occur, the dose should be reduced or treatment discontinued. The dose of the Read the complete document